Home
Biomarin Pharmaceutical BMRN spent $340K on lobbying in Q2 2026 · Health Issues, Medicare and 2 more issues
Trade details
- Type
- Lobbying report
- Amount
- $340,000
- Quarter
- Q2 2026
- Client
- Biomarin Pharmaceutical
- Reported
- 26/07/20
Down 35.8% from last quarter
What else happened in Biomarin Pharmaceutical around then
Filed or reported within 30 days of the trade day · 05/31~07/30Biomarin Pharmaceutical's other lobbying reports
- Biomarin Pharmaceutical
LobbyingBiomarin Pharmaceutical
LobbyingBiomarin Pharmaceutical
BMRN
$50K
$50K
Reported 07/20
for Q2
- Biomarin Pharmaceutical
LobbyingBiomarin Pharmaceutical
LobbyingBiomarin Pharmaceutical
BMRN
$30K
$30K
Reported 07/06
for Q2 2017
- Biomarin Pharmaceutical
LobbyingBiomarin Pharmaceutical
LobbyingBiomarin Pharmaceutical
BMRN
$530K
$530K
Reported 04/20
for Q1
- Biomarin Pharmaceutical
LobbyingBiomarin Pharmaceutical
LobbyingBiomarin Pharmaceutical
BMRN
$50K
$50K
Reported 04/20
for Q1
- Biomarin Pharmaceutical
LobbyingBiomarin Pharmaceutical
LobbyingBiomarin Pharmaceutical
BMRN
$390K
$390K
Reported 01/20
for Q4 2025